CDRH: Concerns Over Emerging Cancer Blood Tests Beyond The Scope Of FDA Authorities

Press/Media

Period6 Dec 2023

Media coverage

1

Media coverage

  • TitleCDRH: Concerns Over Emerging Cancer Blood Tests Beyond The Scope Of FDA Authorities
    Media name/outletInside Health Reform
    Country/TerritoryUnited States
    Date6/12/23
    PersonsMary Kemeny